205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.35%
Positive revenue growth while LSCC is negative. John Neff might see a notable competitive edge here.
8.67%
Positive gross profit growth while LSCC is negative. John Neff would see a clear operational edge over the competitor.
19.59%
Positive EBIT growth while LSCC is negative. John Neff might see a substantial edge in operational management.
19.65%
Positive operating income growth while LSCC is negative. John Neff might view this as a competitive edge in operations.
20.94%
Positive net income growth while LSCC is negative. John Neff might see a big relative performance advantage.
22.22%
Positive EPS growth while LSCC is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
22.58%
Positive diluted EPS growth while LSCC is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-1.03%
Share reduction while LSCC is at 0.63%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.10%
Reduced diluted shares while LSCC is at 0.02%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-0.21%
Dividend reduction while LSCC stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
78.45%
Positive OCF growth while LSCC is negative. John Neff would see this as a clear operational advantage vs. the competitor.
84.17%
Positive FCF growth while LSCC is negative. John Neff would see a strong competitive edge in net cash generation.
75.81%
10Y revenue/share CAGR above 1.5x LSCC's 44.17%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
43.93%
5Y revenue/share CAGR at 50-75% of LSCC's 71.39%. Martin Whitman would worry about a lagging mid-term growth trajectory.
9.01%
3Y revenue/share CAGR above 1.5x LSCC's 5.29%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
139.61%
10Y OCF/share CAGR 1.25-1.5x LSCC's 102.93%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
96.33%
5Y OCF/share CAGR above 1.5x LSCC's 16.53%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
31.16%
Positive 3Y OCF/share CAGR while LSCC is negative. John Neff might see a big short-term edge in operational efficiency.
139.45%
Net income/share CAGR at 50-75% of LSCC's 241.89%. Martin Whitman might question if the firm’s product or cost base lags behind.
81.78%
Below 50% of LSCC's 322.23%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
48.33%
Positive short-term CAGR while LSCC is negative. John Neff would see a clear advantage in near-term profit trajectory.
32.52%
Positive growth while LSCC is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
31.35%
Below 50% of LSCC's 71.14%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
2.49%
Below 50% of LSCC's 22.68%. Michael Burry suspects a serious short-term disadvantage in building book value.
1346.20%
Dividend/share CAGR of 1346.20% while LSCC is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
173.68%
Dividend/share CAGR of 173.68% while LSCC is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
132.62%
3Y dividend/share CAGR of 132.62% while LSCC is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-3.27%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
0.40%
Inventory shrinking or stable vs. LSCC's 9.79%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
0.51%
Asset growth above 1.5x LSCC's 0.10%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
1.09%
50-75% of LSCC's 2.17%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-0.06%
We’re deleveraging while LSCC stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-4.87%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-1.91%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.